George Jeha

George Jeha is an Executive Medical Director at Neurocrine Biosciences, a role held since January 2022. Previously, George served as Medical Director for Rare Disease at BioMarin Pharmaceutical Inc. from August 2017 to January 2022, and was an Assistant Professor at Baylor College of Medicine for over fifteen years, contributing to research focused on the development and differentiation of fat cells and the role of nuclear receptors. George's educational background includes a Doctor of Medicine degree from the American University of Beirut, a BS in Biology from the same institution, Pediatric Residency Training at Upstate Medical University, and Pediatric Endocrinology and Metabolism fellowship training at Baylor College of Medicine.